Inclusive research with individuals with Down syndrome at risk for dementia
View abstract on PubMed
Summary
This summary is machine-generated.Inclusive research partners academics with individuals experiencing health issues. This approach is crucial for studying dementia in people with intellectual disabilities (ID), but requires better guidelines.
Area Of Science
- Public Health
- Neuroscience
- Disability Studies
Background
- Inclusive research is a growing priority to address health disparities and enhance research applicability.
- Individuals with Down syndrome and other intellectual disabilities (ID) have a high risk of dementia and Alzheimer's disease.
- Research on dementia within the ID population is significantly underrepresented and lacks documentation.
Purpose Of The Study
- To describe the evolution of inclusive research concerning intellectual disability (ID) and dementia.
- To outline the challenges and benefits associated with implementing inclusive research in this field.
- To identify key considerations for planning future inclusive studies on ID and dementia.
Main Methods
- Literature review on inclusive research methodologies.
- Analysis of existing studies on dementia in individuals with ID.
- Synthesis of challenges, benefits, and planning aspects for inclusive research.
Main Results
- Inclusive research involving individuals with ID and dementia is an emerging but underdeveloped area.
- Key challenges include ensuring accessibility, ethical rigor, and meaningful co-researcher participation.
- Benefits include advancing equity and scientific quality in underrepresented research fields.
Conclusions
- There is an urgent need for national and international guidelines to support inclusive research for individuals with ID at risk of dementia.
- Developed frameworks must prioritize accessibility, ethical standards, and genuine collaboration.
- Establishing such guidelines will promote equity and improve scientific rigor in this critical research area.
Related Concept Videos
Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
Learning disabilities are cognitive disorders caused by neurological impairments that affect cognitive functions like language and reading, without indicating overall intellectual or developmental challenges. These disabilities differ from global intellectual or developmental disabilities as they are limited to distinct cognitive functions. Common learning disabilities include dysgraphia, dyslexia, and dyscalculia, each of which impacts unique aspects of learning.
Dyslexia
Dyslexia is a...
Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.

